Showing results (611-620 of 1,647) with videos related to

Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|October 4, 2025
Application of Bayesian Borrowing Methods in Clinical Trials for Children with Type II Diabetes MellitusRoberto Crackel, Yuanyuan Ji, Yoonhee Kim, et al.
Therapeutic Innovation & Regulatory Science|April 30, 2025
Quality of Randomized Controlled Trials in the Association of Southeast Asian Nations (ASEAN) - A Systematic ReviewMarlinang Diarta Siburian, Sifa Marie-Joelle Muchanga, Antonio Villanueva, et al.
Therapeutic Innovation & Regulatory Science|April 13, 2025
The Inflation Reduction Act's Impact Upon Early-Stage Venture Capital InvestmentsDuane G Schulthess, Gwen O'Loughlin, Madeline Askeland, et al.
Therapeutic Innovation & Regulatory Science|April 14, 2025
Key Findings from Pharmacovigilance Inspections in Saudi Arabia's Pharmaceutical SectorMalak Almutairi, Salwa Almomen, Amal M Arafah, et al.
Therapeutic Innovation & Regulatory Science|May 22, 2025
Navigating the Trends in USFDA Authorized Generic Approvals (2019-2024): Enhancing Healthcare Accessibility and AffordabilityM Sowndharya, Ramesh Joga, Kajal Gandhi, et al.
Therapeutic Innovation & Regulatory Science|May 13, 2025
Awareness and Attitudes Regarding Adverse Drug Events and Reporting in South AfricaNokukhanya Ncube, Martha S Lubbe, Hanlie Steyn, et al.
Therapeutic Innovation & Regulatory Science|April 22, 2025
The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical TrialsHanke Zheng, Julie A Patterson, Jonathan D Campbell
Therapeutic Innovation & Regulatory Science|November 16, 2025
Regulatory Requirements for Interchangeable Biosimilar DesignationPraveen J Samy, Morgane C Mouslim, Charles L Bennett, et al.
Therapeutic Innovation & Regulatory Science|November 9, 2025
Physician Perceptions and Intentions in Response to Unsupportive Data for Off-label Uses: An Experimental Study with Primary Care Providers and OncologistsKathryn J Aikin, Simani M Price, Amie C O'Donoghue, et al.
Therapeutic Innovation & Regulatory Science|October 16, 2025
Beyond REMS & PDMPs: A Proposed Framework for Next-Generation Opioid RegulationAysha Rana, Kavetha Ram
Pageof 165